专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US6061149A Communication system capable of changing communication protocol 失效
标题翻译：能够改变通信协议的通信系统
公开(公告)号：US6061149A
公开(公告)日：2000-05-09
申请号：US794093
申请日：1997-02-03
申请人： Yuko Hosokawa , Hiroshi Nobuta
发明人： Yuko Hosokawa , Hiroshi Nobuta
IPC分类号： H04L29/06 , H04N1/00 , H04N1/32 , H04N1/333
CPC分类号： H04N1/32635 , H04N1/00206 , H04N1/32609 , H04N1/32673 , H04N1/333 , H04N1/33392
摘要： A communication system in which if the connection between a facsimile apparatus and a host computer such as a PC is confirmed, the facsimile apparatus obtains information on whether or not the host computer is in ready status, as operation information of the host computer. If the host computer is not connected to the facsimile apparatus or it does not in operable state, otherwise the host computer operates but it is in busy status, the facsimile apparatus changes a negotiation protocol between the facsimile apparatus and another facsimile apparatus as the communication destination.
摘要翻译：一种通信系统，其中如果传真机和诸如PC的主计算机之间的连接被确认，则传真装置获取关于主计算机是否处于就绪状态的信息作为主计算机的操作信息。如果主计算机未连接到传真机或者它不处于可操作状态，否则主计算机操作但处于忙状态，则传真设备改变传真设备和作为通信目的地的另一传真设备之间的协商协议。

2. 发明授权

US6090405A Buprenorphine percutaneous absorption preparation 失效
标题翻译：丁丙诺啡经皮吸收制剂
公开(公告)号：US6090405A
公开(公告)日：2000-07-18
申请号：US896948
申请日：1997-07-18
申请人： Kazuhisa Ninomiya , Yasuhiro Fukushima , Mutsuo Okumura , Yuko Hosokawa
发明人： Kazuhisa Ninomiya , Yasuhiro Fukushima , Mutsuo Okumura , Yuko Hosokawa
IPC分类号： A61K9/70 , A61K31/485 , A61K47/14 , A61P25/04 , A61F13/02
CPC分类号： A61K9/7061 , A61K31/485
摘要： Disclosed is a buprenorphine percutaneous absorption preparation comprising a backing having formed on one side thereof a pressure-sensitive adhesive layer containing at least one of buprenorphine and a salt thereof, wherein the pressure-sensitive adhesive layer contains an acrylic copolymer and crosslinked acrylic copolymer particles. The buprenorphine percutaneous absorption preparation has excellent pressure-sensitive adhesive characteristics and exerts excellent percutaneous absorption property.
摘要翻译：公开了一种丁丙诺啡经皮吸收制剂，其包含在其一面上形成含有丁丙诺啡及其盐中的至少一种的压敏粘合剂层的背衬，其中，所述压敏粘合剂层含有丙烯酸共聚物和交联的丙烯酸共聚物颗粒。丁丙诺啡经皮吸收制剂具有优异的压敏粘合剂特性，并且具有优异的经皮吸收性能。

3. 发明授权

US07701967B2 Communication control terminal apparatus, and storage medium 有权
标题翻译：通信控制终端装置和存储介质
公开(公告)号：US07701967B2
公开(公告)日：2010-04-20
申请号：US10241705
申请日：2002-09-12
申请人： Yuko Hosokawa
发明人： Yuko Hosokawa
IPC分类号： H04J3/16
CPC分类号： H04L69/18
摘要： A communication control terminal apparatus employs one CPU to control two or more communication procedures, without adversely affecting each other. The communication control terminal apparatus includes a storage unit for storing information by using predetermined codes, a codec unit for coding and decoding the information, and communication control units for transmitting the information. A communication code obtained by the codec unit through conversion is transmitted via the communication control units. An execution time for the codec unit is changed in accordance with types of the communication procedures performed by the communication control units.
摘要翻译：通信控制终端装置使用一个CPU来控制两个或更多个通信过程，而不会相互影响。通信控制终端装置包括：通过使用预定码存储信息的存储单元，用于对信息进行编码和解码的编解码器单元，以及用于发送信息的通信控制单元。由编解码器单元通过转换获得的通信代码经由通信控制单元发送。编解码器单元的执行时间根据由通信控制单元执行的通信过程的类型而改变。

4. 发明授权

US5869088A Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline 失效
标题翻译：透皮给药制备9-氨基环戊（b）喹啉
公开(公告)号：US5869088A
公开(公告)日：1999-02-09
申请号：US817510
申请日：1997-04-17
申请人： Yuko Hosokawa , Mutsuo Okumura , Mitsuru Ochiai
发明人： Yuko Hosokawa , Mutsuo Okumura , Mitsuru Ochiai
IPC分类号： A61K9/00 , A61K9/70 , A61K31/473 , A61K47/12 , A61K47/14 , A61F13/00
CPC分类号： A61K9/7061 , A61K31/00 , A61K31/473 , A61K47/12 , A61K47/14 , A61K9/0014 , Y10S514/944 , Y10S514/969
摘要： A transdermal administration preparation containing a 9-aminocyclopenta(b)quinoline, preferably 9-amino-2, 3,5,6,7,8-hexahydro-1H-cyclopentane(b)quinoline or its hydrochloride, as an active ingredient and the following transdermal absorption enhancer, that is, at least one compound selected from the group consisting of fatty acids, fatty acid esters, and alcohols, preferably the glyceride of a saturated fatty acid having 6 to 12 carbon atoms.
摘要翻译： PCT No.PCT / JP95 / 02183 Sec。 371日期1997年04月17日 102（e）日期1997年4月17日PCT提交1995年10月24日PCT公布。公开号WO96 / 12495 日期：1996年5月2日一种含有9-氨基环戊（b）喹啉，优选9-氨基-2,3,5,6,7,8-六氢-1H-环戊烷（b）喹啉或其盐酸盐的透皮给药制剂，作为活性成分和以下经皮吸收增强剂，即选自脂肪酸，脂肪酸酯和醇的至少一种化合物，优选具有6至12个碳原子的饱和脂肪酸的甘油酯。

5. 发明授权

US5618555A Percutaneous absorption preparation 失效
标题翻译：经皮吸收制剂
公开(公告)号：US5618555A
公开(公告)日：1997-04-08
申请号：US430384
申请日：1995-04-28
申请人： Shoichi Tokuda , Kazuhisa Ninomiya , Yasuhiro Fukushima , Shigeyuki Watanabe , Mitsuru Ochiai , Mutsuo Okumura , Yuko Hosokawa
发明人： Shoichi Tokuda , Kazuhisa Ninomiya , Yasuhiro Fukushima , Shigeyuki Watanabe , Mitsuru Ochiai , Mutsuo Okumura , Yuko Hosokawa
IPC分类号： A61K9/00 , A61K9/70 , A61K31/485 , A61K47/14 , A61P25/04 , A61F13/00
CPC分类号： A61K9/7061 , A61K31/485 , A61K47/14 , A61K9/0014 , Y10S514/946
摘要： A percutaneous absorption preparation which is excellent in the skin penetration of a non-narcotic analgesic buprenorphine and can sustain a high blood level in a stable state over a long period of time is provided. The percutaneous absorption preparation for administrating buprenorphine hydrochloride and/or buprenorphine, which comprises a support having on one surface thereof a plaster layer containing a pressure-sensitive adhesive, buprenorphine hydrochloride and/or buprenorphine, and a penetration enhancer, wherein the penetration enhancer comprises a combination of a monoglyceride of a fatty acid having 6 to 8 carbon atoms and isopropyl myristate, and the plaster layer contains at least 10% by weight of a monoglyceride off fatty acid having 6 to 8 carbon atoms and at least 5% by weight off isopropyl myristate, with the proviso that the content of the whole penetration enhancer ranges from 25 to 50% by weight. The combined use of the fatty acid monoglyceride and isopropyl myristate as a penetration enhancer synergistically elevates skin penetration of buprenorphine hydrochloride and/or buprenorphine.
摘要翻译：提供了一种在非麻醉性止痛丁丙诺啡的皮肤渗透性优异并能够长期稳定地维持高血液水平的经皮吸收制剂。用于施用盐酸丁丙诺非和/或丁丙诺啡的经皮吸收制剂，其包含在其一个表面上具有含有压敏粘合剂，盐酸丁丙诺非和/或丁丙诺啡的膏药的支持物和渗透促进剂，其中所述渗透促进剂包含具有6至8个碳原子的脂肪酸的单酸甘油酯和肉豆蔻酸异丙酯的组合，所述膏药层含有至少10重量％的具有6至8个碳原子的单酸甘油酯脱脂肪酸和至少5重量％的异丙基肉豆蔻酸酯，条件是全部渗透促进剂的含量为25至50重量％。将脂肪酸单甘油酯和肉豆蔻酸异丙酯作为渗透促进剂的组合使用协同地提高了丁丙诺啡盐酸盐和/或丁丙诺啡的皮肤渗透。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式